“Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study”, Swiss Med Wkly, vol. 144, no. 0708, p. w13880, Feb. 2014, doi: 10.4414/smw.2014.13880.